SPY314.84-2.75 -0.87%
DIA261.04+0.22 0.08%
IXIC10,390.84-226.60 -2.13%

HC Wainwright & Co. Downgrades Inovio Pharmaceuticals to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Inovio Pharmaceuticals (NASDAQ:INO) from Buy to Neutral.

Benzinga · -
HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Inovio Pharmaceuticals (NASDAQ: INO) from Buy to Neutral.